| 000 | 01632 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517053620.0 | ||
| 264 | 0 | _c20160815 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2015.4351 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSyed, Huma | |
| 245 | 0 | 0 |
_aCyclooxygenase I and II inhibitors distinctly enhance hippocampal- and cortex-dependent cognitive functions in mice. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cNov 2015 |
||
| 300 |
_a7649-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAluminum Chloride |
| 650 | 0 | 4 | _aAluminum Compounds |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCelecoxib _xpharmacology |
| 650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
| 650 | 0 | 4 | _aChlorides |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 |
_aCyclooxygenase 1 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 |
_aMemory _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aPiroxicam _xpharmacology |
| 700 | 1 | _aIkram, Muhammad Faisal | |
| 700 | 1 | _aYaqinuddin, Ahmed | |
| 700 | 1 | _aAhmed, Touqeer | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 12 _gno. 5 _gp. 7649-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2015.4351 _zAvailable from publisher's website |
| 999 |
_c25287815 _d25287815 |
||